文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

撒哈拉以南非洲国家COVID-19相关ARDS的呼吸支持技术:一项多中心观察性研究

Respiratory Support Techniques for COVID-19-Related ARDS in a Sub-Saharan African Country: A Multicenter Observational Study.
PubMed 文献 · Chest · 2023-02-10
一句话结论乌干达13家医院499例COVID-19相关ARDS患者中,无创呼吸支持(SOX/HFNO)及清醒俯卧位与较低死亡率相关,但数据为观察性。

该多中心前瞻性观察性研究纳入乌干达13家医院499例COVID-19相关ARDS成人患者,记录初始及最先进呼吸支持技术与28天死亡率。结果显示首选(最先进)呼吸支持技术中SOX占37.3%、HFNO占10%、CPAP占11.6%、NIV占23.4%、IMV占17.6%,19.8%患者升级呼吸支持。28天总死亡率51.9%,不同呼吸支持技术组死亡率分别为SOX 19.9%、HFNO 31.9%、CPAP 58.3%、NIV 61.1%、IMV 83.9%(P < .001)。俯卧位用于15.8%患者(79例中59例为清醒俯卧),与较低死亡率相关(40.5% vs 54%;P = .03)。作者认为在资源有限环境中,SOX、HFNO及清醒俯卧位与较低死亡率相关。

要点

  • 在乌干达13家医院499例COVID-19相关ARDS患者中,首选(最先进)呼吸支持技术为SOX 37.3%、HFNO 10%、CPAP 11.6%、NIV 23.4%、IMV 17.6%。
  • 28天总死亡率为51.9%(轻度ARDS 13.1%、中度62.3%、重度75.7%;P < .001)。
  • 不同呼吸支持技术组28天死亡率分别为SOX 19.9%、HFNO 31.9%、CPAP 58.3%、NIV 61.1%、IMV 83.9%(P < .001)。
  • 俯卧位用于15.8%患者(79例中59例为清醒俯卧),与较低死亡率相关(40.5% vs 54%;P = .03)。
  • 入ICU率38.9%;19.8%患者升级了首选呼吸支持技术。

适用人群与场景

  • 乌干达13家医院收治的成人COVID-19相关ARDS患者,共499例(轻度n=137、中度n=247、重度n=115),ICU入住率38.9%。

研究设计与关键结果

  • 研究类型:多中心、前瞻性、观察性研究;纳入乌干达13家医院499例成人COVID-19相关ARDS患者;记录患者特征、临床和实验室数据、初始及最先进呼吸支持技术及28天死亡率。
  • 首选(最先进)呼吸支持技术:SOX 37.3%(最先进35.3%)、HFNO 10%(9.4%)、CPAP 11.6%(4.8%)、NIV 23.4%(14.4%)、IMV 17.6%(36.6%)。
  • 19.8%患者升级了首选呼吸支持技术。
  • 28天死亡率:总51.9%;轻度ARDS 13.1%、中度ARDS 62.3%、重度ARDS 75.7%(P < .001)。
  • 不同呼吸支持技术组28天死亡率:SOX 19.9%、HFNO 31.9%、CPAP 58.3%、NIV 61.1%、IMV 83.9%(P < .001)。
  • 俯卧位使用79例(15.8%),其中59例为清醒俯卧;俯卧位组死亡率40.5% vs 未俯卧位组54%(P = .03)。
  • 多因素分析:入科时氧饱和度/FiO2比值(OR 0.99;95% CI 0.98-0.99;P < .001)、呼吸频率(OR 1.07;95% CI 1.03-1.12;P = .002)、使用NIV(OR 6.31;95% CI 2.29-17.37;P < .001)或IMV(OR 8.08;95% CI 3.52-18.57;P < .001)为死亡的独立危险因素。

证据类型、等级与局限

  • 证据类型:多中心前瞻性观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在资源有限环境中,使用SOX和HFNO治疗以及清醒俯卧位与COVID-19相关ARDS较低死亡率相关(数据为观察性)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Limited data from low-income countries report on respiratory support techniques in COVID-19-associated ARDS.

RESEARCH QUESTION: Which respiratory support techniques are used in patients with COVID-19-associated ARDS in Uganda?

STUDY DESIGN AND METHODS: A multicenter, prospective, observational study was conducted at 13 Ugandan hospitals during the pandemic and included adults with COVID-19-associated ARDS. Patient characteristics, clinical and laboratory data, initial and most advanced respiratory support techniques, and 28-day mortality were recorded. Standard tests, log-rank tests, and logistic regression analyses were used for statistical analyses.

RESULTS: Four hundred ninety-nine patients with COVID-19-associated ARDS (mild, n = 137; moderate, n = 247; and severe, n = 115) were included (ICU admission, 38.9%). Standard oxygen therapy (SOX), high-flow nasal oxygen (HFNO), CPAP, noninvasive ventilation (NIV), and invasive mechanical ventilation (IMV) was used as the first-line (most advanced) respiratory support technique in 37.3% (35.3%), 10% (9.4%), 11.6% (4.8%), 23.4% (14.4%), and 17.6% (36.6%) of patients, respectively. The first-line respiratory support technique was escalated in 19.8% of patients. Twenty-eight-day mortality was 51.9% (mild ARDS, 13.1%; moderate ARDS, 62.3%; severe ARDS, 75.7%; P < .001) and was associated with respiratory support techniques as follows: SOX, 19.9%; HFNO, 31.9%; CPAP, 58.3%; NIV 61.1%; and IMV, 83.9% (P < .001). Proning was used in 79 patients (15.8%; 59 of 79 awake) and was associated with lower mortality (40.5% vs 54%; P = .03). The oxygen saturation to Fio2 ratio (OR, 0.99; 95% CI, 0.98-0.99; P < .001) and respiratory rate (OR, 1.07; 95% CI, 1.03-1.12; P = .002) at admission and NIV (OR, 6.31; 95% CI, 2.29-17.37; P < .001) or IMV (OR, 8.08; 95% CI, 3.52-18.57; P < .001) use were independent risk factors for death.

INTERPRETATION: SOX, HFNO, CPAP, NIV, and IMV were used as respiratory support techniques in patients with COVID-19-associated ARDS in Uganda. Although these data are observational, they suggest that the use of SOX and HFNO therapy as well as awake proning are associated with a lower mortality resulting from COVID-19-associated ARDS in a resource-limited setting.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Kwizera A, Kabatooro D, Atumanya P, et al. Respiratory Support Techniques for COVID-19-Related ARDS in a Sub-Saharan African Country: A Multicenter Observational Study. Chest. 2023. PMID: 36773933. doi:10.1016/j.chest.2023.01.039

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。